BRIACELL THERAP Income after Tax

Income after Tax of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income after Tax growth rates and interactive chart.


Highlights and Quick Summary

  • Income after Tax for the quarter ending October 31, 2022 was $-1.11 Million (a -111.77% decrease compared to previous quarter)
  • Year-over-year quarterly Income after Tax decreased by -71.37%
  • Annual Income after Tax for 2022 was $-26.8 Million (a 94.26% increase from previous year)
  • Annual Income after Tax for 2021 was $-13.8 Million (a 243.3% increase from previous year)
  • Annual Income after Tax for 2020 was $-4.02 Million (a -7.98% decrease from previous year)
  • Twelve month Income after Tax ending October 31, 2022 was $-412 Thousand (a -98.46% decrease compared to previous quarter)
  • Twelve month trailing Income after Tax decreased by -99.08% year-over-year
Trailing Income after Tax for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
$-412 Thousand $-26.8 Million $-52.3 Million $-44.6 Million
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income after Tax of BRIACELL THERAP

Most recent Income after Taxof BCTX including historical data for past 10 years.

Interactive Chart of Income after Tax of BRIACELL THERAP

BRIACELL THERAP Income after Tax for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-1.11 $9.4 $-4.84 $-3.87 $-26.84
2021 $-27.53 $-16.11 $2.95 $-0.24 $-13.82
2020 $-0.42 $-0.84 $-0.51 $-1.43 $-4.02
2019 $-1.24 $-1.17 $-1.15 $-1.25 $-4.37
2018 $-0.8 $-1.67 $-1.3 $-0.77 $-4.25
2017 $-0.51 $-0.9 $-0.88 $-0.31 $-2.43
2016 $-0.33 $-0.3 $-0.33 $-0.73 $-1.67
2015 $-0.31 $-0.3 $-0.37 $-2.18 $-2.9
2014 $-0.06 $-7.27 $-0.53 $-0.08 $-8.26
2013 $-0.15 $-0.1 $-0.11 $-0.09 $-0.38
2012 $-0.08 $-0.51 $-0.37 $0.01 $-0.99

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology